HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2021

Conditions
Infrarenal Abdominal Aortic AneurysmsAortoiliac Aneurysms
Interventions
DEVICE

Horizon™ Abdominal Aortic Aneurysm Stent Graft System

All patient eligible to undergo stent implantation will receive the Horizon™ Abdominal Aortic Aneurysm Stent Graft System and its designated Delivery System.

Trial Locations (7)

5623

Catharina Ziekenhuis Eindhoven - department of vascula surgery, Eindhoven

8091

Zurich University Hospital- Klinik für Herz- und Gefässchirurgie, Zurich

10128

Azienda Ospedaliera Ordine Mauriziano di Torino, Torino

11000

Clinical Center of Serbia, Clinic for Vascular Surgery, Belgrade

11040

Institute for Cardiovascular Diseases Dedinje, Belgrade

41126

Nuovo Ospedale Civile S. Agostino Estense - Chirurgia vascolare, Modena

42123

Azienda Ospedaliera Arcispedale S. Maria Nuova, Reggio Emilia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Endospan Ltd.

INDUSTRY

NCT02087501 - HORIZON CE Pivotal Study to Treat Abdominal Aortic Aneurysm | Biotech Hunter | Biotech Hunter